Increased Insulin Resistance and Hyperglycaemia in Long COVID: A Systematic Review and Meta-Analysis
Expert Reviews in Molecular Medicine · 2026
DOI: 10.1017/erm.2026.10064 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Expert Reviews in Molecular Medicine, 2026. Verfasst von Abbas F Almulla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technolog…. Hauptthemen laut MEDLINE: Insulin Resistance, Hyperglycemia, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Accumulating evidence suggests that long COVID (LC) is mediated by chronic immune activation, oxidative stress and metabolic dysregulation. These processes may impair glucose homeostasis and promote insulin resistance (IR). However, no prior meta-analysis has systematically and quantitatively evaluated IR indices and related biomarkers in LC compared with normal controls.
Objectives
To systematically review and meta-analyse IR indices including HOMA-IR, HOMA-%B, HOMA-%S, insulin, fasting and random blood sugar (FBG, RBS), glycated haemoglobin (HbA1c), C-peptide and adipokine levels in individuals with LC compared with normal controls.
Methods
PubMed, SCOPUS, SciFinder and Google Scholar databases were searched for relevant studies from inception to September 2025. Fifty-six eligible studies were included, comprising 9623 participants, 5340 LC patients and 4283 normal controls.
Results
LC disease is characterized by elevated HOMA-IR (standardized mean difference, SMD = 0.539; 95% confidence interval, CI: 0.311; 0.766), insulin (SMD = 0.424; 95% CI: 0.113; 0.735), FBG and RBS (SMD = 0.734; 95% CI: 0.190; 1.277, SMD = 0.325; 95% CI: 0.133; 0.517). Furthermore, reduced HOMA-%S was observed in LC patients versus normal controls. Publication bias was generally low, though evidence of small-study effects was observed for several outcomes. The Immunological Confounder Scale was employed to evaluate study quality, revealing an overall intermediate methodological quality.
Conclusions
Our results show that LC is associated with multiple abnormalities in glucose homeostasis, including increased HOMA-IR, hyperglycaemia and impaired insulin sensitivity indices, sustained metabolic disturbances beyond the acute phase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, China.
- Key Laboratory of Psychosomatic Medicine, Chinese Academy of Medical Sciences, Chengdu, 610072, China.
- Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Cognitive Impairment and Dementia Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Innovation in Mental and Physical Health and Clinical Treatment (IMPACT) Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, VIC, Australia.
- Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria.
ORCID-Profile: Abbas F Almulla, Michael Maes
Zitieren
APA
Almulla, A. F., Zhang, Y., Tunvirachaisakul, C., Carvalho, A. F., & Maes, M. (2026). Increased Insulin Resistance and Hyperglycaemia in Long COVID: A Systematic Review and Meta-Analysis. Expert Reviews in Molecular Medicine. https://doi.org/10.1017/erm.2026.10064
Vancouver
Almulla AF, Zhang Y, Tunvirachaisakul C, Carvalho AF, Maes M. Increased Insulin Resistance and Hyperglycaemia in Long COVID: A Systematic Review and Meta-Analysis. Expert Reviews in Molecular Medicine. 2026. doi:10.1017/erm.2026.10064
BibTeX
@article{Almulla2026,
author = {Almulla, Abbas F and Zhang, Yingqian and Tunvirachaisakul, Chavit and Carvalho, Andre F and Maes, Michael},
title = {Increased Insulin Resistance and Hyperglycaemia in Long COVID: A Systematic Review and Meta-Analysis},
journal = {Expert Reviews in Molecular Medicine},
year = {2026},
doi = {10.1017/erm.2026.10064}
}
EUVIMED